Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2786
+0.0177 (6.78%)
At close: Oct 20, 2025, 4:00 PM EDT
0.2700
-0.0086 (-3.09%)
Pre-market: Oct 21, 2025, 7:39 AM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.67 million as of October 21, 2025. Its market cap has decreased by -72.43% in one year.
Market Cap
13.67M
Enterprise Value
11.58M
1-Year Change
-72.43%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.67M, a decrease of -79.30%. That is a compound annual growth rate of -49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 13.67M | -48.59% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |